Transfer of Bone Marrow Derived Stem Cells for the Treatment of Spinal Cord Injury

Inclusion Criteria: * Age 18 to 65 * American Spinal Injury Association Impairment Scale A * Clinical evidence of lesions located below c-spine 5 (C-5) * Confirmation by MRI of injury level * Time between injury and enrollment greater than 2 weeks * Ability to provide informed consent * Platelet count greater than 100 Thousand/uL at screening * INR equal to or less than 1.5 * Hematocrit less than 30% prior to bone marrow aspiration * Spinal cord injury within 60 months of screening Exclusion Criteria: * Anoxic brain injury * Inability to provide consent * Sepsis * Neurological deficits attributed to lesions above C-5 * Cerebro-vascular accidents with intracranial hemorrhage, acute brain injuries, meningitis, hydrocephalus or other potential diseases where the pressure in the cerebro spinal fluid is increased * Multiple sclerosis * Amyotrophic lateral sclerosis * Cerebral Palsy * Evidence of cancer over the last 3 years prior to enrollment * Immunosuppressive diseases * Platelet count lower than 100,000 * White blood count greater than 15,000 unless the patient is on steroids * Bleeding disorders * Clinical or laboratory evidence of meningitis * Skin infection at the infusion site * Pregnant or planning to become pregnant